Top accelerator startups

14,448 startups · 29 programs

Serinus Biosciences

Active · Combinations therapy by rational design

8signal of 100 · rising 2
  • team of 6Team size · YC's directory+4.4
  • went through YCProgram · this site+4

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from S22 in AI

All of S22

About Serinus Biosciences

Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.

YC batch
S22 · Summer 2022
Status, per YC
Active
Category
AI
Team size
6
Location
New York City, NY, USA; New York, NY, USA
Checked
7h ago

YC tags: Biotech, Therapeutics, Oncology

Serinus Biosciences in S22: 233 companies, 54% AI

Serinus Biosciences: questions

Which YC batch was Serinus Biosciences in?

Serinus Biosciences was in Y Combinator's Summer 2022 batch (S22).

Is Serinus Biosciences still active?

Y Combinator lists Serinus Biosciences as active.

Where is Serinus Biosciences based?

Serinus Biosciences lists New York City, NY, USA; New York, NY, USA as its location on YC's directory.